These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8551789)

  • 1. A valveless high stroke volume counterpulsation device restores hemodynamics in patients with congestive heart failure and intractable cardiogenic shock awaiting heart transplantation.
    Nanas JN; Lolas CT; Charitos CE; Nanas SN; Margari ZJ; Agapitos EV; Moulopoulos SD
    J Thorac Cardiovasc Surg; 1996 Jan; 111(1):55-61. PubMed ID: 8551789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High stroke volume para-aortic counterpulsation device versus centrifugal pump in cardiogenic shock: experimental study.
    Nanas SN; Nanas JN; Charitos CE; Gougoulakis A; Makaritsis K; Chatzigeorgiou J; Moussoutzani K; Anastasiou-Nana MI; Moulopoulos SD
    World J Surg; 1997; 21(3):318-2l; discussion 322. PubMed ID: 9015178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superior performance of a paraaortic counterpulsation device compared to the intraaortic balloon pump.
    Terrovitis JV; Charitos CE; Tsolakis EJ; Dolou P; Pierrakos CN; Siafakas KX; Nanas JN
    World J Surg; 2003 Dec; 27(12):1311-6. PubMed ID: 14586569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Additional salutary hemodynamic effects of the combined use of the paraaortic counterpulsation device and intraaortic balloon pump versus a paraaortic counterpulsation device alone.
    Nanas JN; Poyiadjis A; Charitos C; Nanas SN; Kontoyiannis D; Anastasiou-Nana M; Alevizakos N; Voudris V; Moulopoulos SD
    ASAIO Trans; 1990; 36(3):M505-9. PubMed ID: 2252735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intra-aortic counterpulsation for hemodynamic support in patients with acute ischemic versus non-ischemic heart failure.
    Lauten P; Rademacher W; Goebel B; Kretzschmar D; Figulla HR; Lauten A; Ferrari M
    J Invasive Cardiol; 2012 Nov; 24(11):583-8. PubMed ID: 23117313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic effects of a counterpulsation device implanted on the ascending aorta in severe cardiogenic shock.
    Nanas JN; Nanas SN; Charitos CE; Kontoyiannis D; Poyiadjis AD; Stamatopoulos G; Melkaoui A; Kokollis G; Moulopoulos SD
    ASAIO Trans; 1988; 34(3):229-34. PubMed ID: 3196512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of Safety and Effectiveness of the Extracorporeal Continuous-Flow Ventricular Assist Device (BR16010) Use as a Bridge-to-Decision Therapy for Severe Heart Failure or Refractory Cardiogenic Shock: Study Protocol for Single-Arm Non-randomized, Uncontrolled, and Investigator-Initiated Clinical Trial.
    Fukushima N; Tatsumi E; Seguchi O; Takewa Y; Hamasaki T; Onda K; Yamamoto H; Hayashi T; Fujita T; Kobayashi J
    Cardiovasc Drugs Ther; 2018 Aug; 32(4):373-379. PubMed ID: 29948739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maintenance of circulation during ventricular fibrillation with the simultaneous use of two "counterpulsation" devices.
    Nanas JN; Charitos C; Poyiadjis A; Anastasiou-Nana M; Cosmas C; Alevizakos N; Laoutidis G; Moulopoulos S
    ASAIO Trans; 1990; 36(3):M395-7. PubMed ID: 2252709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intra-Aortic Balloon Counterpulsation in Patients With Chronic Heart Failure and Cardiogenic Shock: Clinical Response and Predictors of Stabilization.
    Sintek MA; Gdowski M; Lindman BR; Nassif M; Lavine KJ; Novak E; Bach RG; Silvestry SC; Mann DL; Joseph SM
    J Card Fail; 2015 Nov; 21(11):868-76. PubMed ID: 26164215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of effects of extra-thoracic paraaortic counterpulsation to intraaortic balloon pump on circulatory support in acute heart failure.
    Zhang JM; Liu XC; Liu ZG; Zhao L; Yang L; Liu TW; He GW
    J Cardiothorac Surg; 2015 Nov; 10():173. PubMed ID: 26602754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intra-aortic balloon counterpulsation as a therapy for shock.
    Schott KE
    Crit Care Nurs Clin North Am; 1990 Jun; 2(2):187-93. PubMed ID: 2357321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The left ventricular assist effect and biocompatibility study of a novel para-aortic counterpulsation device.
    Shi C; Zhou DD; Liu G; Zhang L; Meng JJ; Geng Y; Liu XG
    Eur Rev Med Pharmacol Sci; 2015 May; 19(10):1859-65. PubMed ID: 26044232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current concepts in the use of intra-aortic balloon counterpulsation.
    Underwood MJ; Firmin RK; Graham TR
    Br J Hosp Med; 1993 Oct 6-19; 50(7):391-7. PubMed ID: 8261284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extended extra-aortic counterpulsation with the C-Pulse device does not alter aortic wall structure.
    Cheng A; Monreal G; William ML; Sobieski M; Slaughter MS
    ASAIO J; 2014; 60(6):e5-7. PubMed ID: 25158886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ventricular assist device as a bridge to transplant in patients with cardiogenic shock. Preliminary experience in Chile with ABIOMED BVS 5000].
    Castro P; Baraona F; Baeza C; Mc-Nab P; Berlin A; Zalaquett R; Morán S; Becker P; Irarrázabal M; Garayar B; Carvajal M; Cisternas S
    Rev Med Chil; 2006 Aug; 134(8):1019-23. PubMed ID: 17130990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Counterpulsation: historical background, technical improvements, hemodynamic and metabolic effects.
    Nanas JN; Moulopoulos SD
    Cardiology; 1994; 84(3):156-67. PubMed ID: 8205565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute hemodynamic efficacy of a 32-ml subcutaneous counterpulsation device in a calf model of diminished cardiac function.
    Koenig SC; Litwak KN; Giridharan GA; Pantalos GM; Dowling RD; Prabhu SD; Slaughter MS; Sobieski MA; Spence PA
    ASAIO J; 2008; 54(6):578-84. PubMed ID: 19033769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of an extraaortic counterpulsation device in severe cardiac failure.
    Zelano JA; Ko W; Lazzaro R; Lazenby WD; Topaz S; Kolff WJ; Isom OW; Krieger KH
    Ann Thorac Surg; 1992 Jan; 53(1):30-6; discussion 36-7. PubMed ID: 1728239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporary mechanical circulatory support for severe cardiac failure: experimental study.
    Cabrera Fischer EI; Chachques JC; Garcia A; Pichel RH; Morales MC; Carpentier A
    Int J Artif Organs; 1991 Aug; 14(8):466-72. PubMed ID: 1937937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is the Thoratec paracorporeal ventricular assist device a primary or secondary device to support patients with refractory cardiogenic shock?
    Aissaoui N; Diebold B; Fagon JY; Leprince P
    Arch Cardiovasc Dis; 2009; 102(6-7):473-5. PubMed ID: 19664566
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.